Health Professional Radio - Podcast

Dr. Roy Herbst, MD, of Yale Cancer Center and Smilow Cancer Hospital, discusses data presented at the American Society of Clinical Oncology (ASCO20) Virtual Scientific Program highlighting some of the latest research in non-small cell lung cancer (NSCLC) the most common type of lung cancer.

Oswald Peterson, diagnosed in early 2017 with stage 4 non-small cell lung cancer that had spread throughout his body shares his story and talks about the immunotherapy treatments, pembrolizumab (KEYTRUDA®) that shrank his cancer and extended his life. He is an ImmunoAdvocate with the Cancer Research Institute and is passionate about raising awareness around immunotherapy research.

Dr. Steve Shak, Chief Medical Officer at Exact Sciences discusses the publication of new analyses of two clinical studies that demonstrate for the first time the value of the Oncotype DX Genomic Prostate Score® (GPS™) test in guiding treatment plans in patients with unfavorable intermediate (UFI)-risk prostate cancer. The study, published in "Urology", validates the GPS test as a strong independent predictor of critical endpoints in UFI-risk prostate cancer patients, suggesting its benefit in personalizing and improving treatment decisions.

Dr. Thomas Jones, MD, Director of the Cardiac Catheterization Laboratories at Seattle Children's Hospital discusses congenital heart disease and the importance for this patient population to "stay in care" during the COVID-19 pandemic. He also discusses late-breaking data that was presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2020 on the Medtronic Melody™ transcatheter pulmonary valve 10-year study results.

Tom Koulopoulos, Chairman and Founder of Delphi Group, discusses his new book "Reimagining Healthcare: How the Smartsourcing Revolution Will Drive the Future of Healthcare and Refocus It on What Matters Most, the Patient" (Post Hill Press, May 26, 2020)

Cyrus Cooper, president of the International Osteoporosis Foundation (IOF) and professor of Musculoskeletal Science at the University of Oxford, discusses IOF's Capture the Fracture® initiative in partnership with Amgen, UCB, and the University of Oxford. This initiative aims to reduce osteoporosis-related hip and vertebral fractures by 25 percent by 2025, the partners aim to double the 390 existing Capture the Fracture® programs known as Fracture Liaison Services (FLS) by the end of 2022. Osteoporosis affects more than 200 million people worldwide with more than 8.9 million fractures reported in a single year.

Jennifer Thompson, President of Insight Marketing Group discusses the many aspects of marketing in health care such as how to create and control a medical practice’s digital footprint, the importance of online reviews for physician offices, why it's important to put patients forward when it comes to marketing, and other marketing tips.

Dr. Yaron Daniely, PhD, head of aMoon Alpha, an internal section of aMoon, a healthtech and life sciences venture fund based in Israel, discusses his work at aMoon Alpha.

Chris House, Senior Vice President of Product Management and Development at NantHealth®, a healthcare company, discusses NaviNet®, a payer-provider collaboration platform by NantHealth. He also talks about how many health tech companies jumped in to help with COVID-19 initiatives. For instance, during the month of May, NantHealth's NaviNet® AllPayer platform was free to providers.

Dr. Andrew Blumenfeld, MD, director of the Headache Center of Southern California discusses the often misunderstood condition of migraine, how the disease is typically managed, and the latest development in treatment options. VYEPTI™ (eptinezumab-jjmr) is a prescription medicine used for the preventive treatment of migraine in adults.

Dr. Laurie Keefer, PhD, a psychologist with Mount Sinai Hospital’s IBD Center in New York City who specializes in the psychosocial care of patients with chronic digestive diseases, most notably Crohn’s and ulcerative colitis (UC) and Allyson a patient living with UC discuss UC, living with UC and the emotional impact of UC on daily living especially now in the COVID-19 pandemic.

Bruce Boise, who worked in the pharmaceutical industry for over 20 years tells his story and discusses his new book "Cold Comfort: One man's struggle to stop the illegal marketing of powerful opioid drugs and save lives".

Dr. Andrew Krivoshik, SVP, and Oncology Therapeutic Area Head at Astellas Pharma US discusses the overall survival findings from the Phase 3 PROSPER trial in men with non-metastatic castration-resistant prostate cancer (nmCRPC) that was published in the online "New England Journal of Medicine" (NEJM) and also presented during the 2020 American Society of Clinical Oncology (ASCO20) Annual Meeting (Abstract #5515).

Dr. Ayman Al-Hendy, MD, discusses the recent FDA approval of AbbVie’s ORIAHNN™ (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules), a non-surgical, oral medication option, for premenopausal women to manage heavy bleeding due to uterine fibroids.

Lane Conger Maples, VP of Client Experience at Bridge Connector, a company offering interoperability and integration solutions discusses the current state of interoperability and healthcare information technology (HIT) during these unprecedented times brought on by the pandemic. She talks about that despite the financial strains happening across the healthcare industry due to COVID-19, interest and investments in integration technology has remained a priority for healthcare organizations.

Dr. Karim Richard Masri, a Rheumatologist at the Bon Secours Rheumatology center in Richmond, VA discusses new data released by Horizon Therapeutics at the Annual European Congress of Rheumatology (EULAR 2020) that shows the benefit of combining immunomodulators with KRYSTEXXA® (pegloticase injection) to help more people with uncontrolled gout achieve complete and durable responses. Other data shared at EULAR addressed the rate of amputation reinforcing the systemic and potentially devastating impact of uncontrolled gout. Dr. Masri also discusses details for prescribers on how to ensure patients are supported during COVID-19.

Dr. W. Michael Korn, Chief Medical Officer at Caris Life Sciences® and Dr. Philip A. Philip, who serves as the Kathryn Cramer, MD, Endowed Chair in Cancer Research and an investigator on this study discuss the data presentation from the American Society of Clinical Oncology, (ASCO20) Virtual Scientific Program, Abstract 4629/Poster 237: Enrichment of alterations in targetable molecular pathways are enriched in KRAS wild-type (WT) pancreatic cancer (PC).

Dr. Chadi Nabhan, Chairman of Precision Oncology Alliance™ at Caris Life Sciences® and Dr. Stephen Liu, an oncologist with Medstar Health and an investigator on this study discuss the data presentation from the American Society of Clinical Oncology, (ASCO20) Virtual Scientific Program, Abstract 9544/Poster 310: Characterization of KRAS mutations in non-small cell lung cancer (NSCLC).

Returning guest, Dr. Jacqueline A. Nicholas, MD, MPH, discusses multiple sclerosis (MS) and MS relapses. She talks about the recently FDA approved ZEPOSIA® (ozanimod) a new oral therapy to treat appropriate adult patients with relapsing forms of MS and other complications.

Dr. Rollie Carlson, CEO of Immunexpress discusses the development and commercialization plans for SeptiCyte® RAPID. SeptiCyte® RAPID is a test that quantifies the immune response to infection and will provide actionable results in about one hour to guide physicians when making patient management decisions.